TY  - CONF

T1  - TWO-YEAR SURVIVAL WITH AXICABTAGENE CILOLEUCEL IN RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA: AN UPDATED ANALYSIS

JO  - HemaSphere

PY  - 2019/06/26

AU  - Diakite I

AU  - Lin VW

AU  - Klijn S

AU  - Navale L

AU  - Purdum AG

AU  - Fenwick E

AU  - Botteman M

AU  - van Hout B

ED  - 

DO  - DOI: 10.1097/01.hs9.0000565632.15112.c4

PB  - Ovid Technologies (Wolters Kluwer Health)

VL  - 3

SP  - 817

EP  - 817

Y2  - 2024/10/22

ER  -